CLINICAL_TRIALS
research
· 2024-06-21
Clinical Trial Update: A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection [Phase 2]
Summary
A Phase 2a study of IV BCV for adenovirus infection is currently recruiting, with cytomegalovirus infection also listed among the conditions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SymBio Pharmaceuticals | Conditions: Adenovirus Infections, Cytomegalovirus Infection | Phase 2 | Status: RECRUITING